Search alternatives:
teer decrease » greater decrease (Expand Search)
ms decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » greater decrease (Expand Search)
ms decrease » _ decrease (Expand Search), nn decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1421
-
1422
-
1423
Decreased production of antiviral factors in patients infected with SARS-CoV-2 due to reduced TLR7 expression
Published 2025“…<p>The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic presents a major global health challenge. …”
-
1424
-
1425
Transient neonatal olfactory deprivation causes a persistent decrease in the addition of CR+ PGCs. A
Published 2012“…. & reopening group was used as a control (control). The number of PGCs was quantified at P61. …”
-
1426
-
1427
-
1428
Mean RRCPs in V1 and ventral category-selective areas (FFA and PPA).
Published 2013“…In general, similarly to the mean response amplitudes (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0072728#pone-0072728-g004" target="_blank">Figure 4</a>), the RRCPs decreased as the eccentricity increased in V1 (p<0.001, A, B) and ventral category-selective areas (FFA and PPA, C, D). …”
-
1429
-
1430
Substance P decreases PRL immunoreactivity in human epidermis.
Published 2013“…<p>Epidermal PRL IR (black arrows) was examined in full-thickness human skin organ culture. (A) PRL IR in the control group was significantly greater than that in (B) Substance P treated skin. …”
-
1431
-
1432
-
1433
-
1434
-
1435
-
1436
-
1437
-
1438
-
1439
-
1440
The effects of pretreatment with fingolimod-phosphate on BMECs in the presence of MS sera.
Published 2015“…Pretreatment with fingolimod-phosphate resulted in an increase in the claudin-5 protein levels (B) and TEER values (G) and a decrease in the VCAM-1 protein levels (F) in the BMECs, which were upregulated after exposure to the sera from all MS patients, including the RRMS-R, RRMS-S and SPMS patients, compared to that observed in the cells not pretreated with fingolimod-phosphate.…”